Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.94
+0.57 (8.95%)
At close: May 21, 2026, 4:00 PM EDT
7.06
+0.12 (1.73%)
After-hours: May 21, 2026, 6:20 PM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $434.07 million as of May 21, 2026. Its market cap has increased by 203.60% in one year.
Market Cap
434.07M
Enterprise Value
323.98M
1-Year Change
203.60%
Ranking
Category
Stock Price
$6.94
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $434.07M, an increase of 604.44%. That is a compound annual growth rate of 45.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 391.13M | 2.60% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 410.65M |
| Century Therapeutics | 405.80M |
| Lexeo Therapeutics | 402.03M |
| Lyell Immunopharma | 401.79M |
| Enanta Pharmaceuticals | 395.76M |
| Zura Bio | 387.59M |
| Artiva Biotherapeutics | 380.93M |
| Greenwich LifeSciences | 378.51M |